<DOC>
	<DOCNO>NCT01012284</DOCNO>
	<brief_summary>The purpose study ass pharmacokinetics ( body medication ) , safety tolerability TMC207 N-monodesmethyl metabolite ( M2 ) healthy participant patient moderate hepatic impairment administration single 400 mg dose TMC207 .</brief_summary>
	<brief_title>A Study TMC207 Patients With Moderately Impaired Hepatic Function</brief_title>
	<detailed_description>This Phase I , open label ( people know identity intervention ) study TMC207 . The study consist screen period 4-weeks treatment period . Sixteen participant enrol two panel . Panel A include 8 patient moderate hepatic impairment Panel B include 8 healthy participant . Safety evaluation include adverse event , clinical laboratory test , electrocardiogram , vital sign , physical examination monitor throughout study . The entire study duration participant approximately 7 week .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Bedaquiline</mesh_term>
	<mesh_term>Diarylquinolines</mesh_term>
	<criteria>For healthy participant Panel A : Healthy basis physical examination , medical history , vital sign , electrocardiogram clinical laboratory test perform screen Should match patient hepatic impairment regard sex , age ( less 5 year ) , body mass index For patient Panel B moderate hepatic impairment : history hepatic disease , document liver cirrhosis moderate liver function impairment define ChildPugh classification A positive tuberculin skin test indicate latent tuberculosis A positive human immunodeficiency virus ( HIV ) 1 HIV2 test screen Moderate hepatic impairment patient acute hepatitis , Hepatic carcinoma , Grade 3 4 encephalopathy , active candidate liver transplantation Matched healthy participant current active hepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Moderate Hepatic Impairment</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>TMC207</keyword>
	<keyword>Mycobacterial adenosine triphosphate ( ATP ) -synthase</keyword>
</DOC>